<DOC>
	<DOCNO>NCT02114476</DOCNO>
	<brief_summary>The purpose study determine effect implantable contraception incidence diabetes mellitus woman history gestational diabetes mellitus compare use nonhormonal contraceptive .</brief_summary>
	<brief_title>Effect Implantable Contraception Type-2 DM Metabolic Syndrome Women With History Gestational DM</brief_title>
	<detailed_description>Gestational diabetes mellitus ( GDM ) define abnormal glucose tolerance detect first time pregnancy . GDM well-known risk factor develop overt diabetes later life , especially type 2 diabetes . About 50-60 % woman prior GDM develop type 2 diabetes lifetime . Recent study show woman previous GDM exhibit markedly increase prevalence metabolic syndrome , even glucose tolerance normal . For maternal future offspring , woman prior GDM need safe , efficient , acceptable choice contraceptive method enhance already substantial risk develop either overt diabetes metabolic syndrome associate sequela . The intrauterine device ( IUD ) effective reversible contraceptive method without metabolic disturbance therefore ideal contraceptive woman prior GDM . Progestins increase globulin production ; thus , increase coagulation factor blood pressure . A nonrandomized open-label prospective trial healthy obese , reproductive-age woman California study metabolic effect progestin-only long-acting reversible contraception levonorgestrel-releasing intrauterine system ( LNG-IUS ) etonogestrel implant ( ENG-I ) ] compare nonhormonal contraception ( NHC ) . The change fast glucose insulin sensitivity see among obese 3 month .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Progestins</mesh_term>
	<criteria>Postpartum woman diagnosis gestational diabetes mellitus Want use implant contraception nonhormonal contraception IUD tubal sterilization Age le 18 year old Diagnosis diabetes mellitus post partum period Cardiovascular disease , Liver disease , autoimmune disease The woman reject continue study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>GDM</keyword>
	<keyword>implant</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>metabolic syndrome</keyword>
</DOC>